Bright Light Therapy for Treatment of Sleep Problems Following Mild Traumatic Brain Injury

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-12-31

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the research study is to understand the effectiveness of a six-week course of light exposure on cognitive functioning, mood, activity, and sleep in people that have suffered a head injury leading to a concussion.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Improving Sleep in Veterans With TBI

NCT03785600

Traumatic Brain Injury

COMPLETED NA

TWILIGHT Study: Effect of Light Exposure During Acute Rehabilitation on Sleep After TBI

NCT02214212

Traumatic Brain Injury TBI Sleep

COMPLETED NA

Morning Bright Light to Improve Sleep Quality in Veterans

NCT03578003

Brain Injuries, Traumatic Post-traumatic Stress Disorder

RECRUITING NA

Improving Sleep, Sleep-related Outcomes, and Biomarkers in Veterans

NCT03968874

Traumatic Brain Injury

ACTIVE_NOT_RECRUITING NA

Transcranial Photobiomodulation in Anxiety Disorders

NCT07133893

Symptoms of Anxiety

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mild traumatic brain injuries (mTBI) or "concussions" are an increasingly prevalent injury in the investigators society. Patients with post-concussion syndrome have been shown to have deficits on tests of short term memory, divided attention, multi-tasking, information processing speed, and reaction time, as well as alteration in mood and emotional functioning. Many patients have other vague complaints including fatigue, dizziness, irritability, sleep disturbances, and chronic headaches. Furthermore, sleep disruption of one of the most common complaints in patients suffering from traumatic brain injuries, with as many as 40 to 65% of patients with mTBI complaining of insomnia. Sleep problems in these patients are associated with poorer outcome, while resolution of the sleep disturbance is associated with improvement in cognitive functioning.

Despite recent evidence of the correlation between sleep quality and recovery from traumatic brain injury, and the well-established role of sleep in neural plasticity and neurogenesis, there have been virtually no direct studies of the causal effects of sleep on recovery following mTBI. However, it is quite likely that sleep plays a critical role in recovery following brain injury.

A particularly promising non-pharmacologic approach that shows potential in improving/modifying abnormalities of the circadian rhythm and sleep-wake schedule is bright light therapy. For the proposed investigation, the investigators hypothesize that bright light therapy may be helpful in improving the sleep of patients with a recent history of mTBI and may also have other mood elevating effects, both of which should promote positive treatment outcome in these individuals. Bright light therapy may increase the likelihood that they will recover more quickly, benefit more extensively from other forms of therapy, and build emotional and cognitive resilience.

This study will also have a healthy control (HC)/effect localization arm that will assist in identifying and mapping the brain systems before and after light exposure so that researchers may develop further insights into the relationship between concussion, light exposure, sleep, and brain function. This healthy control arm will also provide brain targets for study in the analysis of the Main Study Arm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Concussion, Mild Post-Concussion Symptoms Sleep Problems

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mTBI wavelength-1 bright light

30 minutes daily light exposure for 6 weeks

Group Type EXPERIMENTAL

mTBI wavelength-1 bright light

Intervention Type DEVICE

6 weeks of daily light exposure, 30 minutes per morning

mTBI wavelength-2 bright light

30 minutes daily light exposure for 6 weeks

Group Type PLACEBO_COMPARATOR

mTBI wavelength-2 bright light

Intervention Type DEVICE

6 weeks of daily light exposure, 30 minutes per morning

HC wavelength-1 bright light

30 minutes of light exposure

Group Type EXPERIMENTAL

HC wavelength-1 bright light

Intervention Type DEVICE

30 minutes of light exposure

HC wavelength-2 bright light

30 minutes of light exposure

Group Type PLACEBO_COMPARATOR

HC wavelength-2 bright light

Intervention Type DEVICE

30 minutes of light exposure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

mTBI wavelength-1 bright light

6 weeks of daily light exposure, 30 minutes per morning

Intervention Type DEVICE

mTBI wavelength-2 bright light

6 weeks of daily light exposure, 30 minutes per morning

Intervention Type DEVICE

HC wavelength-1 bright light

30 minutes of light exposure

Intervention Type DEVICE

HC wavelength-2 bright light

30 minutes of light exposure

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age range between 18 and 50.
* The primary language of the subjects must be English.
* Subjects have experienced a "concussion" or mTBI within the preceding 18 months, but no sooner that 4 weeks prior to their screening. The occurrence of a concussion or mTBI must be documented by a medical report or other professional witness documentation.
* If documented, Glasgow Coma Scale in the range of 13-15 following the injury.
* Subjects must have complaints of sleep difficulties that emerged or worsened following the most recent head injury.
* At least half of subjects must have evidence of sleep onset insomnia or delayed sleep phase disorder.

Exclusion Criteria

* Any other history of neurological illness, current Diagnostic Statistical Manual (DSM-IV) Axis I disorder, lifetime history of psychotic disorder, or head injury with loss of consciousness \> 30 minutes
* Complicating medical conditions that may influence the outcome of neuropsychological assessment or functional imaging (e.g., HIV, brain tumor, etc.)
* Abnormal visual acuity that is not corrected by contact lenses
* Metal within the body, claustrophobia, or other contraindications for neuroimaging
* Less than 9th grade education
* Excess current alcohol use (more than 2 instances of intake of 5+ drinks (men) when or 4+ drinks (women) when drinking in the past two months, and/or on average drinking \> 2 drinks per day (men); \> 1 drinks per day (women) during the past two months
* History of alcoholism or substance use disorder
* Significant use of illicit drugs
* History of marijuana use within the past 6 weeks and/or use of marijuana before the age of 16.

Subjects who engage in shift-work, night work, or who have substantially desynchronized work-sleep schedules (i.e., sleeping later than 10:00 a.m. more than once a week) will be excluded.

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes